“Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients With Type 2 Diabetes: Single-Blind Interventional Study With Placebo Control at Tertiary Care Setting Quetta”. 2025. Life and Science 6 (4): 06. https://doi.org/10.37185/LnS.1.1.870.